14-23422190-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PM5PP2
The NM_000257.4(MYH7):c.3235C>G(p.Arg1079Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1079Q) has been classified as Pathogenic.
Frequency
Consequence
NM_000257.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The Arg1079Gly variant in MYH7 has not been reported in individuals with cardiom yopathy or in large population studies. Other variants at this position have bee n reported (Arg1079Gly: Girolami 2010, Waldmuller 2011, LMM unpublished data; Ar g10479Trp: dbSNP rs192722540), though their significance is unclear. Arginine at position 1079 is not conserved in mammals or evolutionarily distant species, th ough the change to glycine (Gly) was predicted to be pathogenic using a computat ional tool clinically validated by our laboratory. This tool's pathogenic predic tion is estimated to be correct 94% of the time (Jordan 2011). At this time, add itional information is needed to fully assess the clinical significance of the A rg1079Gly variant. -
not provided Uncertain:1
p.Arg1079Gly (CGG>GGG): c.3235 C>G in exon 25 of the MYH7 gene (NM_000257.2). The R1079G mutation in the MYH7 gene has not been reported as a disease-causing mutation or as a benign polymorphism to our knowledge. R1079G results in a non-conservative amino acid substitution as these residues differ in polarity, charge, size and/or other properties and is more likely to impact secondary structure. The R1079 residue is conserved across mammals. A mutation in this same residue (R1079Q) has been reported in association with cardiomyopathy, and has been observed at GeneDx in one affected patient referred for HCM testing, supporting the functional importance of this residue. The R1079G mutation was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. In silico algorithms are not consistent in their predictions but at least two concur that R1079G is damaging to the protein structure/function. In summary, R1079G in the MYH7 gene is interpreted as a likely disease-causing mutation. The variant is found in HCM panel(s). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at